Ausgabe 13/2012
Inhalt (7 Artikel)
Editorial
Developing New Drugs for Diabetes and Cardiometabolic Disorders
Andrew J. Krentz, Linda Morrow, Marcus Hompesch
Current Opinion
Will Abuse-Deterrent Formulations of Opioid Analgesics Be Successful in Achieving Their Purpose?
Bernard Bannwarth
Leading Article
Polymorphisms of Estrogen Receptors and Risk of Depression
Joanne Ryan, Marie-Laure Ancelin
Review Article
New Oral Anticoagulants
Birgitte Klindt Poulsen, Erik Lerkevang Grove, Steen Elkjaer Husted
Systematic Review
Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients
Ida Ehlers Albertsen, Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Thure Filskov Overvad, Gregory Y. H. Lip
Adis Drug Evaluation
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)
Paul L. McCormack